Division of Substance Use Disorders

Displaying 151 - 153 of 153CSV
Greiner, M. G., Shulman, M., Choo, T.-H., Scodes, J., Pavlicova, M., Campbell, A. N. C., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2021). Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse. Journal of Substance Abuse Treatment, 131, 108447. https://doi.org/10.1016/j.jsat.2021.108447
Publication Date
Columbia Affiliation
View
Scopus Record
More Information
Ross, J., Slawek, D. E., Zhang, C., Starrels, J. L., Levin, F. R., Sohler, N. L., Minami, H., Arnsten, J. H., & Cunningham, C. O. (2021). First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort Study. Pain Medicine, 22(12), 3080–3088. https://doi.org/10.1093/pm/pnab257
Publication Date
Columbia Affiliation
View
Scopus Record
More Information

Murphy, S. M., Jeng, P. J., McCollister, K. E., Leff, J. A., Jalali, A., Shulman, M., Lee, J. D., Nunes, E. V., Novo, P., Rotrosen, J., & Schackman, B. R. (2021). Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. Addiction (Abingdon, England), 116(12), 3444–3453. https://doi.org/10.1111/add.15531

Publication Date
Columbia Affiliation
View
Scopus Record
More Information
CSV